₹ 10.05
-0.15 (-1.47%)
N
Nectar Lifesciences
₹ 10.05
Nectar Lifesciences Fundamentals
Company Valuation
Market Cap (₹ Cr.)
195
PE Ratio
-0.80
PB Ratio
0.34
Dividend Yield
-
ROE
-9.85%
ROCE
-8.69%
Book Value (₹)
29.97
Face Value (₹)
1.00
Analyse NECLIFE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Jan 2026 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 44.91% | 51.84% | 51.84% | 51.84% | 51.84% |
| Domestic Institutional Investors (DII) | 5.82% | 3.54% | 4.01% | 3.74% | 3.90% |
| Foreign Institutional Investors (FII) | 0.52% | 0.58% | 0.60% | 0.50% | 0.50% |
| Public Investors | 39.72% | 35.83% | 36.23% | 37.58% | 37.62% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NECLIFE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
532649
NSE Scrip Name
NECLIFE
ISIN
INE023H01027

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






